rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
45
|
pubmed:dateCreated |
2009-11-11
|
pubmed:abstractText |
Regulatory T cells (Tregs) can suppress a wide range of immune cells, making them an ideal candidate for the treatment of autoimmunity. The potential clinical translation of targeted therapy with antigen-specific Tregs is hampered by the difficulties of isolating rare specificities from the natural polyclonal T cell repertoire. Moreover, the initiating antigen is often unknown in autoimmune disease. Here we tested the ability of antigen-specific Tregs generated by retroviral gene transfer to ameliorate arthritis through linked suppression and therefore without cognate recognition of the disease-initiating antigen. We explored two distinct strategies: T cell receptor (TCR) gene transfer into purified CD4+CD25+ T cells was used to redirect the specificity of naturally occurring Tregs; and co-transfer of FoxP3 and TCR genes served to convert conventional CD4(+) T cells into antigen-specific regulators. Following adoptive transfer into recipient mice, the gene-modified T cells engrafted efficiently and retained TCR and FoxP3 expression. Using an established arthritis model, we demonstrate antigen-driven accumulation of the gene modified T cells at the site of joint inflammation, which resulted in a local reduction in the number of inflammatory Th17 cells and a significant decrease in arthritic bone destruction. Together, we describe a robust strategy to rapidly generate antigen-specific regulatory T cells capable of highly targeted inhibition of tissue damage in the absence of systemic immune suppression. This opens the possibility to target Tregs to tissue-specific antigens for the treatment of autoimmune tissue damage without the knowledge of the disease-causing autoantigens recognized by pathogenic T cells.
|
pubmed:grant |
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-10323452,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-10899917,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-11067961,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-11812990,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-12522256,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-12612578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-14530324,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-14634133,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15184499,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15591438,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15931392,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-15972960,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16473830,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16772372,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16818678,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-16917003,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17114489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17130300,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17210729,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17220874,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17440104,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17620361,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17878367,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-17984976,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18024188,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18066074,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18490709,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18617638,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18809613,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-18846251,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19036923,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19050237,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19350586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-19955436,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-7636184,
http://linkedlifedata.com/resource/pubmed/commentcorrection/19884493-9885918
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1091-6490
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
10
|
pubmed:volume |
106
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
19078-83
|
pubmed:dateRevised |
2010-9-28
|
pubmed:meshHeading |
pubmed-meshheading:19884493-Adoptive Transfer,
pubmed-meshheading:19884493-Animals,
pubmed-meshheading:19884493-Arthritis, Rheumatoid,
pubmed-meshheading:19884493-Autoantigens,
pubmed-meshheading:19884493-Flow Cytometry,
pubmed-meshheading:19884493-Gene Transfer Techniques,
pubmed-meshheading:19884493-Genetic Vectors,
pubmed-meshheading:19884493-Immunotherapy, Adoptive,
pubmed-meshheading:19884493-Mice,
pubmed-meshheading:19884493-Mice, Inbred C57BL,
pubmed-meshheading:19884493-Retroviridae,
pubmed-meshheading:19884493-T-Cell Antigen Receptor Specificity,
pubmed-meshheading:19884493-T-Lymphocytes, Regulatory
|
pubmed:year |
2009
|
pubmed:articleTitle |
Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis.
|
pubmed:affiliation |
Department of Immunology, University College London, Royal Free Hospital, London NW3 2PF, United Kingdom.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|